Neuberger Berman Group LLC X4 Pharmaceuticals, Inc Transaction History
Neuberger Berman Group LLC
- $114 Billion
- Q1 2025
A detailed history of Neuberger Berman Group LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 44,667 shares of XFOR stock, worth $144,274. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,667Holding current value
$144,274% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XFOR
# of Institutions
100Shares Held
97.9MCall Options Held
500KPut Options Held
20.4K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$54.6 Million1.36% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$48.4 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$34.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.07MShares$26.1 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY7.31MShares$23.6 Million1.22% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $222M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...